Moreover, we identified for the first time that inosine, a gut microbial purine metabolite, contributed to the protective effects of BL against DSS-induced colitis by improving A2AR/PPARγ-dependent mucosal barrier functions (Additional file 1: Fig. S5). This evidence concerns the gene ADORA2A and colitis.